In the CY 2026 Physician Fee Schedule Proposed Rule, CMS outlines a single national payment rate (~$125.38/cm²) and shifts certain skin-substitute payments to incident-to supplies, changes that could reshape pricing dynamics for placental allografts in physician offices.
Mid-July 2025, policy analysts highlighted CMS’s proposed CY 2026 changes for physician-office use of skin substitutes, including a uniform per-cm² rate (~$125.38) and treating these products as incident-to supplies. While still proposed (not final), the policy aims to curb spending variability and could narrow price differentials among products—especially relevant for placental allografts (amnion/chorion, umbilical cord matrices). If finalized, clinics may re-evaluate product selection based on clinical evidence, handling characteristics, and outcomes rather than price dispersion alone. Stakeholders should monitor the rulemaking process and submit comments before finalization.
Get in touch with our team to discuss your healthcare needs